arrow
J

Joshua T. Kantrowitz

new york state psychiatric institute
H指数:38
被引数:4,987

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study

鲁瓦达克西STAT在治疗伴有认知障碍的精神分裂症成人中的2期随机对照试验:ERUDITE研究的结果

2026-04-240
OAAI
Feasibility of a digital therapeutic for experiential negative symptoms of schizophrenia: results from an exploratory study

数字疗法对精神分裂症体验性阴性症状的可行性:一项探索性研究的结果

2025-09-260
OAAI
Assessing the inter-rater reliability of the Schizophrenia Cognition Rating Scale: a non-interventional quantitative study

评估Schizophrenia Cognition Rating Scale的评分者间信度:一项非干预性定量研究

2025-04-280
OA
Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo- Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist D-serine
2023-07-0116
OAAI
Illness Phase as a Key Assessment and Intervention Window for Psychosis
2023-07-011
OAAI
Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2022-07-126
OA
Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia
2021-08-2316
OA